Sodium Intake and Mortality in the NHANES II Follow-up Study



      US Dietary Guidelines recommend a daily sodium intake <2300 mg, but evidence linking sodium intake to mortality outcomes is scant and inconsistent. To assess the association of sodium intake with cardiovascular disease (CVD) and all-cause mortality and the potential impact of dietary sodium intake <2300 mg, we examined data from the Second National Health and Nutrition Examination Survey (NHANES II).


      Observational cohort study linking sodium, estimated by single 24-hour dietary recall and adjusted for calorie intake, in a community sample (n = 7154) representing 78.9 million non-institutionalized US adults (ages 30-74). Hazard ratios (HR) for CVD and all-cause mortality were calculated from multivariable adjusted Cox models accounting for the sampling design.


      Over mean 13.7 (range: 0.5-16.8) years follow-up, there were 1343 deaths (541 CVD). Sodium (adjusted for calories) and sodium/calorie ratio as continuous variables had independent inverse associations with CVD mortality (P = .03 and P = .008, respectively). Adjusted HR of CVD mortality for sodium <2300 mg was 1.37 (95% confidence interval [CI]: 1.03-1.81, P = .033), and 1.28 (95% CI: 1.10-1.50, P = .003) for all-cause mortality. Alternate sodium thresholds from 1900-2700 mg gave similar results. Results were consistent in the majority of subgroups examined, but no such associations were observed for those <55 years old, non-whites, or the obese.


      The inverse association of sodium to CVD mortality seen here raises questions regarding the likelihood of a survival advantage accompanying a lower sodium diet. These findings highlight the need for further study of the relation of dietary sodium to mortality outcomes.


      To read this article in full you will need to make a payment


      Subscribe to The American Journal of Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


      1. U.S. Department of Health and Human Services, U.S. Department of Agriculture. Dietary guidelines for Americans. Available at: http://www health gov/dietaryguidelines/dga2005/document/pdf/DGA2005 pdf 2005. Accessed March 10, 2005.

        • Sacks F.M.
        • Svetkey L.P.
        • Vollmer W.M.
        • et al.
        Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet.
        N Engl J Med. 2001; 344: 3-10
        • Graudal N.A.
        • Galloe A.M.
        • Garred P.
        Effects of sodium restriction on blood pressure, renin, aldosterone, catecholamines, cholesterols, and triglyceride.
        JAMA. 1998; 279: 1383-1391
        • Alderman M.H.
        • Madhavan S.
        • Ooi W.L.
        • Cohen H.
        • Sealey J.E.
        • Laragh J.H.
        Association of the renin-sodium profile with the risk of myocardial infarction in patients with hypertension.
        N Engl J Med. 1991; 324: 1098-1104
        • Grassi G.
        • Dell’Oro R.
        • Seravalle G.
        • Foglia G.
        • Trevano F.Q.
        • Mancia G.
        Short- and long-term neuroadrenergic effects of moderate dietary sodium restriction in essential hypertension.
        Circulation. 2002; 106: 1957-1961
        • Petrie J.R.
        • Morris A.D.
        • Minamisawa K.
        • et al.
        Dietary sodium restriction impairs insulin sensitivity in noninsulin-dependent diabetes mellitus.
        J Clin Endocrinol Metab. 1998; 83: 1552-1557
        • Kagen A.
        • Popper J.S.
        • Rhoads G.G.
        • Yano K.
        Dietary and other risk factors for stroke in Hawaiian Japanese men.
        Stroke. 1985; 16: 390-396
        • Alderman M.H.
        • Madhavan S.
        • Cohen H.
        • Sealey J.E.
        • Laragh J.H.
        Low urinary sodium is associated with greater risk of myocardial infarction among treated hypertensive men.
        Hypertension. 1995; 25: 1144-1152
        • Tunstall-Pedoe H.
        • Woodward M.
        • Tavendale R.
        • A’Brook R.
        • McCluskey M.K.
        Comparison of the prediction by 27 different factors of coronary heart disease and death in men and women of the Scottish heart health study.
        BMJ. 1997; 315: 722-729
        • Alderman M.H.
        • Cohen H.
        • Madhavan S.
        Dietary sodium intake and mortality.
        Lancet. 1998; 351: 781-785
        • He J.
        • Ogden L.G.
        • Vupputuri S.
        • Bassano L.A.
        • Loria C.
        • Whelton P.K.
        Dietary sodium intake and subsequent risk of cardiovascular disease in overweight adults.
        JAMA. 1999; 282: 2027-2034
        • Cohen J.D.
        • Grandis G.
        • Cutler J.A.
        • Neaton J.D.
        • Kuller L.H.
        • Stamler J.
        Dietary sodium intake and mortality.
        Circulation. 1999; 100: 1-524
        • Tuomilehto J.
        • Jousilahti P.
        • Rastenyte D.
        • et al.
        Urinary sodium excretion and cardiovascular mortality in Finland.
        Lancet. 2001; 347: 848-851
        • Nagata C.
        • Takatsuka N.
        • Shimizu N.
        • Shimizu H.
        Sodium intake and risk of death from stroke in Japanese men and women.
        Stroke. 2004; 15: 1543-1547
      2. US Department of Health and Human Services, Centers for Disease Control and Prevention. The Second National Health and Nutrition Examination Survey (1976-1980). Available at: Accessed March 10, 2005.

        • Loria C.M.
        • Sempos C.T.
        • Vuong C.
        Plan and operation of the NHANES II Mortality Study 1992.
        Vital Health Stat. 1999; 38: 1-16
      3. The International Classification of Diseases 9th Revision Clinical Modification (1998 ICD-9-CM), 5th ed. Burr Ridge, IL: Practice Management Information Corp.; 1997.

        • Cox D.R.
        Regression models and life tables (with discussion).
        J R Stat Soc. 1972; 334: 187-220
        • Willett W.
        • Stampfer M.J.
        Total energy intake.
        Am J Epidemiol. 1986; 124: 17-27
        • Intersalt
        An international study of electrolyte excretion and blood pressure: results for 24-h urinary sodium and potasium excretion: Intersalt Cooperative Research Group.
        BMJ. 1988; 297: 310-328
        • Schulz K.F.
        • Grimes D.A.
        Multiplicity in randomised trials II.
        Lancet. 2005; 365: 1657-1661
        • Hooper L.
        • Bartlett C.
        • Davey S.G.
        • Ebrahim S.
        Advice to reduce salt for prevention of cardiovascular disease.
        Cochrane Database Syst Rev. 2004; 1 (CD003656)
        • Willett W.
        Nutritional Epidemiology. 2nd ed. Oxford University Press, Oxford, England1998
        • Mattes R.D.
        The taste for salt in humans.
        Am J Clin Nutr. 1997; 65: 692S-697S
        • Kuznetsova T.
        • Staessen J.A.
        • Stolarz K.
        • et al.
        European Project on Genes in Hypertension (EPOGH) Investigators. Relationship between left ventricular mass and the ACE D/I polymorphism varies according to sodium intake.
        J Hypertens. 2004; 22: 287-295
      4. United States Department of Agriculture. Nutrition and your health: dietary guidelines for Americans; Part D: Science base; Section 7: Fluid and electrolytes. Available at: http://www health gov/dietaryguidelines/dga2005/report/HTML/D7_Fluid htm. Accessed March 10, 2005.

        • Darbar D.
        • Fromm M.F.
        • Dellorto S.
        • Roden D.M.
        Sympathetic activation enhances QT prolongation by quinidine.
        J Cardiovasc Electrophysiol. 2001; 12: 9-14
        • Hozawa A.
        • Ohkubo T.
        • Kikuya M.
        • et al.
        Prognostic value of home heart rate for cardiovascular mortality in the general population.
        Am J Hypertens. 2004; 17: 1005-1010
        • Feldman R.D.
        • Schmidt N.D.
        Moderate dietary salt restriction increases vascular and systemic insulin resistance.
        Am J Hypertens. 1999; 12: 643-647
        • Bjorntorp P.
        • Holm G.
        • Rosmond R.
        Hypothalamic arousal, insulin resistance and Type 2 diabetes mellitus.
        Diabet Med. 1999; 16: 373-383
        • McCarty M.F.
        Elevated sympathetic activity may promote insulin resistance syndrome by activating alpha-1 adrenergic receptors on adipocytes.
        Med Hypotheses. 2004; 62: 830-838
        • Simpson J.W.
        • Lawless R.W.
        • Mitchell A.C.
        Responsibility of the obstetrician to the fetus. II. Influence of prepregnancy weight and pregnancy weight gain on birthweight.
        Obstet Gynecol. 1975; 45: 481-487